Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study
- Junzhe Yi
- Jiongliang Wang
- Yimin Zhang
- Xiongying Jiang
- Song Chen
- Jie Xu
- Xintong Wu
- Suixing Zhong
- Qifeng Chen
- Yue Hu
- Yujia Song
- Genjun Tan
- Yunan Zhang
- Jibin Li
- Ming Zhao
- Ning Lyu
2026-05-18